Corline Biomedical AB Market Cap

Corline Biomedical AB has a market cap or net worth of 408.54 million as of April 28, 2026. Its market cap has increased by 81.71% in one year.

Market Cap

408.54M

Enterprise Value

387.98M

Revenue

8.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

15.80

Market Cap Chart

Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 408.54M, an increase of 317.02%. That is a compound annual growth rate of 13.98%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	408.54M	15.91%
Dec 30, 2025	352.45M	86.79%
Dec 30, 2024	188.69M	-41.07%
Dec 29, 2023	320.21M	61.61%
Dec 30, 2022	198.15M	-36.85%
Dec 30, 2021	313.77M	25.86%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Intervacc AB	411.70M
Ascelia Pharma AB	383.78M
Sprint Bioscience AB	328.15M
Bio-Works Technologies AB	314.18M
Oncopeptides AB	539.17M
Mendus AB	311.04M
FluoGuide	701.39M
Xintela AB	228.24M

Market Cap Rankings